Literature DB >> 16822520

Production of Alexa Fluor 488-labeled reovirus and characterization of target cell binding, competence, and immunogenicity of labeled virions.

Ronald J Fecek1, Ryan Busch, Hong Lin, Kasturi Pal, Cynthia A Cunningham, Christopher F Cuff.   

Abstract

Respiratory enteric orphan virus (reovirus) has been used to study many aspects of the biology and genetics of viruses, viral infection, pathogenesis, and the immune response to virus infection. This report describes the functional activity of virus labeled with Alexa Fluor 488, a stable fluorescent dye. Matrix assisted laser desorption-time of flight analysis indicated that Alexa Fluor 488 labeled the outer capsid proteins of reovirus. Labeled virus bound to murine L929 fibroblasts as determined by flow cytometry and fluorescence microscopy, and the specificity of binding were demonstrated by competitive inhibition with non-labeled virus. Labeled reovirus induced apoptosis and cytopathic effect in infected L929 cells. Mice infected with labeled virus mounted robust serum antibody and CD8(+) T-cell responses, indicating that labeled virus retained immunogenicity in vivo. These results indicate that Alexa Fluor 488-labeled virus provides a powerful new tool to analyze reovirus infection in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822520     DOI: 10.1016/j.jim.2006.05.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Transport to late endosomes is required for efficient reovirus infection.

Authors:  Bernardo A Mainou; Terence S Dermody
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

2.  Enteric reovirus infection stimulates peanut-specific IgG2a responses in a mouse food allergy model.

Authors:  Ronald J Fecek; Marisa Marcondes Rezende; Ryan Busch; Ine Hassing; Raymond Pieters; Christopher F Cuff
Journal:  Immunobiology       Date:  2010-03-04       Impact factor: 3.144

3.  Optimum length and flexibility of reovirus attachment protein σ1 are required for efficient viral infection.

Authors:  Magdalena Bokiej; Kristen M Ogden; Mine Ikizler; Dirk M Reiter; Thilo Stehle; Terence S Dermody
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

4.  Labeling of influenza viruses with synthetic fluorescent and biotin-labeled lipids.

Authors:  Natalia A Ilyushina; Evgeny S Chernyy; Elena Y Korchagina; Aleksandra S Gambaryan; Stephen M Henry; Nicolai V Bovin
Journal:  Virol Sin       Date:  2014-07-31       Impact factor: 4.327

5.  Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry.

Authors:  Amanda A Anafu; Christopher H Bowen; Christopher R Chin; Abraham L Brass; Geoffrey H Holm
Journal:  J Biol Chem       Date:  2013-05-06       Impact factor: 5.157

6.  Confocal Microscopy of Reovirus Transport in Living Dorsal Root Ganglion Neurons.

Authors:  Pavithra Aravamudhan; Krishnan Raghunathan; Terence S Dermody
Journal:  Bio Protoc       Date:  2020-11-20

7.  De Novo Isolation & Affinity Maturation of yeast-displayed Virion-binding human fibronectin domains by flow cytometric screening against Virions.

Authors:  Pete Heinzelman; Alyssa Low; Rudo Simeon; Gus A Wright; Zhilei Chen
Journal:  J Biol Eng       Date:  2019-10-16       Impact factor: 4.355

8.  Reovirus uses macropinocytosis-mediated entry and fast axonal transport to infect neurons.

Authors:  Pavithra Aravamudhan; Krishnan Raghunathan; Jennifer Konopka-Anstadt; Amrita Pathak; Danica M Sutherland; Bruce D Carter; Terence S Dermody
Journal:  PLoS Pathog       Date:  2020-02-28       Impact factor: 6.823

9.  Reovirus infection is regulated by NPC1 and endosomal cholesterol homeostasis.

Authors:  Paula Ortega-Gonzalez; Gwen Taylor; Rohit K Jangra; Raquel Tenorio; Isabel Fernandez de Castro; Bernardo A Mainou; Robert C Orchard; Craig B Wilen; Pamela H Brigleb; Jorna Sojati; Kartik Chandran; Martin Sachse; Cristina Risco; Terence S Dermody
Journal:  PLoS Pathog       Date:  2022-03-09       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.